MEDIA ADVISORY:Maxwell Biosciences to Present at the Upcoming 2021 Spring Private Company Showcase Hosted by Credit Suisse, Solebury Trout, and Cooley

Written By Guest User

WHO: Joshua McClure, CEO and co-founder of Maxwell Biosciences, a bioscience company that develops antiviral drugs, designed to be Zero-Day Therapeutics, which have been shown in preclinical studies to destroy a broad spectrum of viruses including rapidly evolving CoronaVirus strains, will present an overview of the company at 2021 Spring Private Company Showcase hosted by Credit Suisse, Solebury Trout, and Cooley

WHAT: Maxwell Biosciences will present at the upcoming 2021 Spring Private Company Showcase hosted by Credit Suisse, Solebury Trout, and Cooley. During the 20-minute presentation, participants will be able to submit questions electronically with answers provided at the discretion of the company on an individual basis afterwards.  

WHERE: A virtual presentation for participants; To access the presentation, please login here: https://troutaccess.com/index.php/cc/springpcs21/5cd5ed24ee94002ea07c2f7e425de6d6 

WHEN: Thursday, March 11, at 2:40 p.m. EDT


Media Contacts

Lana McGilvray, Purpose Worldwide, 512-970-8310, lana@purposenorthamerica.com

Alexis Roberts, Purpose Worldwide, alexis@purposenorthamerica.com 


Guest User
Previous

NPR Webcast featuring Maxwell Biosciences Chief Scientific Officer: Science, Rhetoric and Society
Next

Maxwell Biosciences Appoints Kent Kirshenbaum, Ph.D. as Chief Scientific Officer and Sheetal Vali, Ph.D. as Director of Drug Development